Arcturus Therapeutics Holdings, Inc. (ARCT)

8.90 -0.23 (-2.52%) USD  |  NASDAQ  |  May 07, 16:00
8.39 -0.51 (-5.73%) Pre-Market: 08:31
More

Arcturus Therapeutics Holdings Research and Development Expense (Annual) : 96.10M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ARCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Twist Bioscience Corp. 80.28M
STAAR Surgical Co. 39.28M
Denali Therapeutics, Inc. 418.78M
Quantum-Si, Inc. 53.45M
Agenus, Inc. 79.34M